Analyst Ratings For Solid Biosciences (NASDAQ:SLDB)
Today, Instinet initiated coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy with a price target of $52.00.
Some recent analyst ratings include
- 2/20/2018-Instinet initiated coverage with a Buy rating.
- 2/20/2018-Leerink Swann initiated coverage with a Outperform rating.
- 2/20/2018-JPMorgan Chase & Co. initiated coverage with a Neutral rating.
- 2/20/2018-Goldman Sachs Group initiated coverage with a Neutral rating.
Recent Trading Activity for Solid Biosciences (NASDAQ:SLDB)
Shares of Solid Biosciences closed the previous trading session at 24.58 down -0.35 1.40% with 23.010000228881836 shares trading hands.